xRead - Olfactory Disorders (September 2023)

20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

668

INTERNATIONAL CONSENSUS ON OLFACTION

1590. Levy LM, Henkin RI, Lin CS, Hutter A, Schellinger D. Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comput Assist Tomogr . 1998;22:760–770. 1591. Henkin RI, Velicu I, Schmidt L. Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides. Am JMedSci . 2011;341:17–22. 1592. Henkin RI, Hosein S, Stateman WA, Knöppel AB, Abdelmeguid M. Improved smell function with increased nasal mucus sonic hedgehog in hyposmic patients after treat ment with oral theophylline. Am J Otolaryngol . 2017;38:143– 147. 1593. Stafford LD, Damant K, Ashurst S, Parker MO. Higher olfac tory sensitivity to coffee odour in habitual caffeine users. Exp Clin Psychopharmacol . 2020;28:245–250. 1594. Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey WH, Hanson LR. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol . 2012;64:1709–1714. 1595. Ketterer C, Heni M, Thamer C, Herzberg-Schäfer SA, Häring HU, Fritsche A. Acute, short-term hyperinsulinemia increases olfactory threshold in healthy subjects. Int J Obes (Lond) . 2011;35:1135–1138. 1596. Brünner YF, Benedict C, Freiherr J. Intranasal insulin reduces olfactory sensitivity in normosmic humans. J Clin Endocrinol Metab . 2013;98:1626–1630. 1597. Thanarajah SE, Hoffstall V, Rigoux L, Hanssen R, Brüning JC, Tittgemeyer M. The role of insulin sensitivity and intranasally applied insulin on olfactory perception. Sci Rep . 2019;10; 9: 7222. 1598. Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H. Post prandial administration of intranasal insulin intensifies sati ety and reduces intake of palatable snacks in women. Diabetes . 2012;61:782–789 1599. Rezaeian A. Effect of intranasal insulin on olfactory recovery in patients with hyposmia: A randomized clinical trial. Oto laryngol Head Neck Surg . 2018;158:1134–1139. 1600. Schöpf V, Kollndorfer K, Pollak M, Mueller CA, Freiherr J. Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: A pilot study. Rhinology . 2015;53:371–378. 1601. Degerman, E, Rauch, U, Lindberg, S, Caye-Thomasen, P, Hultgårdh, A, Magnusson, M. Expression of insulin signalling components in the sensory epithelium of the human saccule. Cell Tissue Res . 2013;352:469–478. 1602. Yan CH, Mundy DC, Patel ZM. The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study. Laryngo scope Investig Otolaryngol . 2020;5:187–193. 1603. Mavrogeni P, Kanakopoulos A, Maihoub S, Maihoub S, Krasznai M, Szirmai A. Anosmia treatment by platelet rich plasma injection. Int Tinnitus J . 2016;20:102–105. 1604. Tutar B, Ekincioglu E, Karaketir S, et al. The impact of platelet rich fibrin (PRF) on olfactory function and pain after septo plasty operations. Eur Arch Otorhinolaryngol . 2020;277:1115– 1120. 1605. Ikumi A, Hara Y, Yoshioka T, Kanamori A, Yamazaki M. Effect of local administration of platelet-rich plasma (PRP) on peripheral nerve regeneration: An experimental study in the rabbit model. Microsurg . 2018;38:300–309.

1570. Duncan R, Briggs M. Treatment of uncomplicated anosmia by vitaminA. Arch Otolaryngol . 1962;75:116–124. 1571. Kartal D, Yaşar M, Kartal L, Özcan I, Borlu M. Effects of isotretinoin on the olfactory function in patients with acne. An Bras Dermatol . 2017;92:191–195. 1572. Hummel T, Whitcroft K, Rueter G, Haehner A. Intranasal vita min A is beneficial in post-infectious olfactory loss. EurArch Otorhinolaryngol . 2017;274:2819–2825. 1573. Intranasal retinoic acid treatment for patients with olfac tory loss: a randomized controlled trial. ClinicalTrials.gov identifier: NCT03574701. Accessed June 22, 2021. https:// clinicaltrials.gov/ct2/show/NCT03574701 1574. Uchida J, Furuta A, Suzaki H. Kampo treatment on the cases of olfactory dysfunction. Otorhinolaryngol Neurosci . 2009;23:20– 21. 1575. Ogawa T, Kato T, Tojima I, Shibayama M, Shimizu T. Clini cal study of olfactory dysfunction after upper respiratory infec tion. Jpn J Taste Smell Res . 2010;17:511–514. 1576. Jonas M, Cunha BA. Minocycline. Ther Drug Monit . 1982;4:137–145. 1577. Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol . 2013;169:337–352. 1578. Lees KA, Orlandi RR, Oakley G, Alt JA. The role of macrolides and doxycycline in chronic rhinosinusitis. Immunol Allergy Clin North Am . 2020;40:303–315. 1579. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. ClinTher . 2005;27:1329–1342. 1580. Plane JM, Shen Y, Pleasure DE, Deng W. Prospects for minocy cline neuroprotection. Arch Neurol . 2010;67:1442–1448. 1581. Kern RC, Conley DB, Haines GK 3rd, Robinson AM. Treat ment of olfactory dysfunction, II: Studies with minocycline. Laryngoscope . 2004;114:2200–2204. 1582. Conley DB, Robinson AM, Shinners MJ, Kern RC. Age-related olfactory dysfunction: cellular and molecular characterization in the rat. AmJRhinol . 2003;17:169–75. 1583. Vent J, Robinson AM, Gentry-Nielsen MJ, Conley DB, Hallworth R, Leopold DA, Kern RC. Pathology of the olfac tory epithelium: smoking and ethanol exposure. Laryngoscope . 2004;114:1383–1388. 1584. Reden J, Herting B, Lill K, Kern R, Hummel T. Treatment of postinfectious olfactory disorders with minocycline: a double blind, placebo-controlled study. Laryngoscope . 2011;121:679– 682. 1585. Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. AmJ MedSci . 2009;337:396–406. 1586. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theo phylline treatment of hyposmia and hypogeusia: A pilot study. Arch Otolaryngol Head Neck Surg . 2012;138:1064– 1070. 1587. Meusel T, Albinus J, Welge-Luessen A, Hähner A, Hummel T. Short-term effect of caffeine on olfactory function in hyposmic patients. Eur Arch Otorhinolaryngol . 2016;273:2091–2095. 1588. Gudziol V, Hummel T. Effects of pentoxifylline on olfactory sensitivity: a postmarketing surveillance study. Arch Otolaryn gol Head Neck Surg . 2009;135:291–295. 1589. Whitcroft KL, Gudziol V, Hummel T. Short-course pentox ifylline is not effective in post-traumatic smell loss: A pilot study. Ear Nose Throat J . 2020;99:58–61.